barriers to getting a glp-1 medication prescribed The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs GLP-1 Medications: Everything You Need

Rise Ella McGovern for medical writing assistance and administrative support during the preparation of this manuscript

Because every barrier to enrollment is another reason someone might turn to an unsafe alternative

Observational studies indicate a potential reduced risk of developing dementia, including Alzheimers, in patients using GLP-1 agonists [16, 23]

Heres how subcutaneous injections differ from other types of injections: Subcutaneous (under the skin): Absorbed slowly, ideal for medications that work over time

The current evidence on semaglutide (Ozempic, Ryblesus, Wegovy), liraglutide (Saxenda, Victoza, Xultophy), and dulaglutide (Trulicity) does not show a similar effect

It can be used long-term if effective and well tolerated.